Bladder cancer trials in France

In France 70 Also abroad 626

70 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence
Where
Amiens
Age
18 years and over
People
500
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT05204186
No phaseTaking people
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Where
Toulouse
Age
18 years and over
People
450
Run by
Institut Claudius Regaud
See details and how to joinNCT06967961
Phase 1Not yet taking people in France
Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)
Where
Saint-Herblain
Age
18 years and over
People
24
Run by
Institut Cancerologie de l'Ouest
See details and how to joinNCT07260162
No phaseEnrolling by invitation
Real-World Outcomes of First-Line Treatment of Metastatic or Locally Advanced Upper Tract Urothelial Carcinoma With Enfortumab Vedotin Plus Pembrolizumab : A French Multicenter Retrospective Observational Study
Where
Nîmes
Age
18 years and over
People
50
Run by
Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT07633353
No phaseTaking people
MICROBIOTA AND BLADDER CANCER
Where
Cannes, Marseille, Menton, Nice, Nîmes, Paris, Rennes, Tours
Age
18 years and over
People
95
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07080333
Phase 2Taking people
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Where
Bordeaux, Caen Cedex 5, Clermont-Ferrand, Dijon, Marseille, Paris, Pierre-Bénite, Poitiers
Age
18 years and over
People
101 worldwide
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00
Phase 2Taking people
Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer
Where
Paris
Age
18 years and over
People
320 worldwide
Run by
Queen Mary University of London
See details and how to joinNCT06892860
No phaseTaking people
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
Where
Aix-en-Provence, Angers, Arras, Aubergenville, Beauvais, Caen, Cesson-Sévigné, Cornebarrieu, Eaubonne, La Roche-sur-Yon, Le Kremlin-Bicêtre, Le Mans, Le Puy-en-Velay, Levallois-Perret, Lorient, Lyon, Mantes-la-Jolie, Marseille, Martigues, Meaux, Montpellier, Nîmes, Paris, Perpignan, Pontoise, Pringy, Quint-Fonsegrives, Rouen, Royan, Saintes, Saint-Germain-en-Laye, Saint-Grégoire, Saint-Herblain, Saint-Jean, Saint-Nazaire, Suresnes, Tarbes, Toulouse
Age
18 years and over
People
8,000
Run by
Association Francaise d'Urologie
See details and how to joinNCT05002556
No phaseTaking people
Bio Clinical Collection of Urothelial Carcinoma
Where
Toulouse
Age
18 years to 99 years
People
1,000
Run by
University Hospital, Toulouse
See details and how to joinNCT04970472
No phaseTaking people
Association Between the SPHERTEST in Vitro Test and Response to Checkpoint Inhibitor Treatments in Patients With Advanced or Metastatic Urothelial Carcinoma
Where
Montpellier, Nice, Nîmes, Toulouse
Age
18 years and over
People
32
Run by
Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT06738797
No phaseTaking people
Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial Carcinoma
Where
Strasbourg
Age
18 years and over
People
50
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07339878
No phaseTaking people
Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs
Where
Colmar, Strasbourg
Age
18 years and over
People
340
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07334314
Phase 2Taking people
Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations
Where
Clermont Ferrand Cedex1, Lyon, Paris, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
90 worldwide
Run by
Spanish Oncology Genito-Urinary Group
See details and how to joinNCT06511648 · EU 2024-512573-27-01
No phaseTaking people
Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers
Where
Suresnes
Age
18 years and over
People
66
Run by
Hopital Foch
See details and how to joinNCT06537960
Phase 2Taking people
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy
Where
Albi, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dunkirk, Lille, Marseille, Nice, Paris, Pau, Saint-Herblain, Saint-Mandé, Saint-Priest-en-Jarez, Toulouse, Villejuif
Age
18 years and over
People
130
Run by
Institut Claudius Regaud
See details and how to joinNCT04428554
Phase 2Taking people
TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma
Where
Angers, Besancon Cedex, Brest, Caen Cedex 5, Clermont-Ferrand, Dijon, Lyon, Marseille, Nice Cedex 2, Paris, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Herblain Cedex, Toulouse
Age
18 years and over
People
50
Run by
Centre Francois Baclesse
See details and how to joinNCT04678362 · EU 2024-516182-37-01
Phase 2Taking people
Safety and Efficacy of Neoadjuvant immunotherapy with Durvalumab (MEDI 4736) in combination with neoadjuvant chemotherapy (Gemcitabin/Cisplatin or Gemcitabin/Carboplatin) in patients with operable, high-risk, localized urothelial carcinoma of the upper urinary tract. iNDUCT - GETUG V08
Where
Nîmes
Age
18 years and over
People
50
Run by
Centre Hospitalier Universitaire De Nimes
See details and how to join2024-516077-72-02 · EU 2024-516077-72-02
No phaseTaking people
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Where
Lille, Villejuif
Age
18 years and over
People
200 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767
No phaseTaking people
Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
Where
Amiens
Age
18 years and over
People
500
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT05415631
No phaseTaking people
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Where
Bron, Lyon, Pierre-Bénite
Age
18 years and over
People
410
Run by
Hospices Civils de Lyon
See details and how to joinNCT03787056